Get startedLog in
    Picture of Intra-Cellular Therapies logo

    ITCI — Intra-Cellular Therapies News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Johnson & Johnson To Acquire Intra-Cellular Therapies for $14.6 billion

    Picture of Intra-Cellular Therapies logoIntra-Cellular Therapies
    13/01/2025 11:50
    Jan 13 (Reuters) - 
    Johnson & Johnson  JNJ.N :
    * JOHNSON & JOHNSON STRENGTHENS NEUROSCIENCE LEADERSHIP WITH
ACQUISITION OF INTRA-CELLULAR THERAPIES, INC.
    * JOHNSON & JOHNSON - DEAL VALUED AT $14.6 BILLION, $132 PER
SHARE


Source text:  ID:nBw5kQR01a 
Further company coverage:  JNJ.N 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Intra-Cellular Therapies

    See all news